BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2769330)

  • 21. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial.
    Kulig J; Kolodziejczyk P; Sierzega M; Bobrzynski L; Jedrys J; Popiela T; Dadan J; Drews M; Jeziorski A; Krawczyk M; Starzynska T; Wallner G
    Oncology; 2010; 78(1):54-61. PubMed ID: 20215786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer.
    Ueda Y; Sonoda Y; Fujiki H; Harada S; Kimura T; Itoh T; Imura K; Naito K; Nomura K; Taniwaki M; Yamagishi H
    Oncol Rep; 2004 Aug; 12(2):323-32. PubMed ID: 15254697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial.
    Lerner A; Gonin R; Steele GD; Mayer RJ
    J Clin Oncol; 1992 Apr; 10(4):536-40. PubMed ID: 1548518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of curatively operated gastric cancer with peritonitis carcinomatosa treated by intraperitoneal administration of CDDP.Etoposide and EAP therapy].
    Sakata Y; Okamura T; Kurimoto H; Ono K; Uenishi M
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2829-32. PubMed ID: 7993123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
    Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
    [No Abstract]   [Full Text] [Related]  

  • 26. [Successful treatment of two patients with advanced gastric cancer by neoadjuvant chemotherapy with EAP regimen].
    Matsumura T; Ohnoshi T; Ueoka H; Kiura K; Tabata M; Genba K; Chikamori M; Ikubo S; Matsuo K; Kimura I
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):261-4. PubMed ID: 8311499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated EAP chemotherapy].
    Uchinami M; Horiuchi T; Aotake T; Matsumura M; Yokomachi J; Tanaka K; Tabo T; Tanigawa N
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):449-53. PubMed ID: 11915738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced gastric cancer with multiple lymph node metastasis successfully treated with etoposide, adriamycin and cisplatin.
    Shigemitsu K; Naomoto Y; Matsuno T; Gochi A; Isozaki H; Tanaka N
    J Gastroenterol Hepatol; 2001 May; 16(5):581-5. PubMed ID: 11350560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination chemotherapy with etoposide, ADM, and CDDP (EAP) for advanced gastric cancer].
    Taguchi T; Ohta J; Orino M; Ohshiba S; Yamada S; Okazima K; Ohtani T; Hurukawa H; Iwanaga T; Numata N
    Gan To Kagaku Ryoho; 1990 Nov; 17(11):2191-6. PubMed ID: 2241183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
    Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
    Hayakawa M; Morise K; Sakai T; Thin K; Ando T; Kokubu K; Akatsuka Y; Sato Y; Tahara H; Kuwahara Y
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3393-8. PubMed ID: 2508565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.
    Menges M; Schmidt C; Lindemann W; Ridwelski K; Pueschel W; Jüngling B; Feifel G; Schilling M; Stallmach A; Zeitz M
    J Cancer Res Clin Oncol; 2003 Jul; 129(7):423-9. PubMed ID: 12836016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of EAP (etoposide, adriamycin, cis-platinum) on patients with advanced gastric cancer: the role of EAP as neoadjuvant chemotherapy and histopathological study on its effect].
    Tsujinaka T; Murata A; Ogawa M; Kido Y; Shiozaki H; Miyamoto T; Kanbayashi J; Kobayashi K; Tahara H; Miyata M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3295-8. PubMed ID: 2782922
    [No Abstract]   [Full Text] [Related]  

  • 35. Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.
    Gebbia V; Valenza R; Testa A; Sciume C; Longo A; Cipolla C; Borsellino N; Leo P; Latteri M; Florena M
    J Cancer Res Clin Oncol; 1994; 120(9):550-2. PubMed ID: 8045920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer.
    Newman E; Marcus SG; Potmesil M; Sewak S; Yee H; Sorich J; Hayek M; Muggia F; Hochster H
    J Gastrointest Surg; 2002; 6(2):212-23; discussion 223. PubMed ID: 11992807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The German EORTC Study of neoadjuvant therapy of stomach carcinoma].
    Siewert JR; Schuhmacher C; Fink U
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():717-9. PubMed ID: 9931709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.
    Yeh KH; Cheng AL; Chen YC; Chen BR; Lee WJ; Lin JT; Lee PH; Chang KJ; Wang CH; Wang TH
    J Formos Med Assoc; 1994 Jan; 93(1):20-4. PubMed ID: 7915575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.